| Financial Year |
March 31 2023 |
| Monetary Funds |
14,458,474,995.37 |
| Held-for-trading Financial Assets |
85,646,883.17 |
| Notes Receivable |
2,202,720,144.84 |
| Accounts Receivable |
3,259,431,777.79 |
| Advances to Suppliers |
457,539,057.82 |
| Other Receivables |
56,254,117.17 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,790,598,613.23 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
54,581,111.11 |
| Other Current Assets |
182,329,092.88 |
| Total Current Assets |
23,547,575,793.38 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,432,562,509.67 |
| Investment Properties |
6,191,475.43 |
| Fixed Assetes |
5,230,295,232.48 |
| Under-construction Projects |
909,461,674.66 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
832,112,818.49 |
| R&D expenses |
300,157,334.73 |
| Goodwill |
636,339,503.82 |
| Long-Term Deferred and Prepaid Expenses |
290,036,796.09 |
| Deferred Income Tax Assets |
506,141,586.79 |
| Other Non-Current Assets |
1,312,195,031.38 |
| Sub-Total of Non-Current Assets |
12,645,475,221.68 |
| Total Assets |
36,193,051,015.06 |
| Short-Term Loans |
2,099,069,713.00 |
| Trading Financial liabilities |
4,759,250.98 |
| Notes Payable |
1,659,215,210.65 |
| Accounts Payable |
1,044,610,610.21 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
361,917,343.05 |
| Taxes Payable |
302,213,706.06 |
| Interest Payable |
-- |
| Dividend Payable |
11,892,804.66 |
| Other payables |
3,650,990,302.39 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
65,000,820.80 |
| Other Current Liabilities |
88,863,541.97 |
| Sub-Total of Current Liabilities |
9,395,021,446.59 |
| Long-term Loans |
3,666,476,993.70 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
232,294,155.75 |
| Other Non-Current Liabilities |
90,000,000.00 |
| Sub-Total of Non-Current Liabilities |
4,450,336,415.73 |
| Total Liabilities |
13,845,357,862.33 |
| Paid-In Capital(Or Share Stock) |
1,929,189,374.00 |
| Capital Surplus |
2,541,441,353.22 |
| Surplus Reserve |
734,766,581.50 |
| LESS:Treasury Stock |
717,135,581.08 |
| Undistributed Profits |
8,919,389,509.85 |
| Minority Stockholder's Interest |
8,982,622,820.65 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
13,365,070,332.09 |
| Owner's Equity（Stockholder's Equity） |
22,347,693,152.74 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
36,193,051,015.06 |
